Bicocca Open Archive

Logo unimib boa
CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.598
AS - Asia 10.575
EU - Europa 8.253
SA - Sud America 1.231
AF - Africa 163
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 23
Totale 35.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.207
SG - Singapore 3.532
CN - Cina 2.470
VN - Vietnam 1.987
DE - Germania 1.503
IT - Italia 1.479
HK - Hong Kong 1.318
RU - Federazione Russa 1.273
SE - Svezia 1.067
BR - Brasile 1.027
IE - Irlanda 837
UA - Ucraina 538
GB - Regno Unito 461
CA - Canada 281
IN - India 251
KR - Corea 226
FI - Finlandia 213
FR - Francia 211
ID - Indonesia 168
AT - Austria 149
JP - Giappone 137
NL - Olanda 97
AR - Argentina 92
TR - Turchia 91
BD - Bangladesh 90
ZA - Sudafrica 80
MX - Messico 78
DK - Danimarca 76
LT - Lituania 76
PL - Polonia 70
AU - Australia 56
ES - Italia 50
BE - Belgio 46
IQ - Iraq 45
IR - Iran 43
EC - Ecuador 34
PK - Pakistan 34
EG - Egitto 25
SA - Arabia Saudita 23
TW - Taiwan 22
EU - Europa 20
IL - Israele 18
NZ - Nuova Zelanda 18
RO - Romania 18
KZ - Kazakistan 17
PY - Paraguay 17
VE - Venezuela 16
CO - Colombia 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 13
MY - Malesia 13
UZ - Uzbekistan 13
MA - Marocco 12
CZ - Repubblica Ceca 11
UY - Uruguay 11
BG - Bulgaria 10
PT - Portogallo 10
HR - Croazia 9
TN - Tunisia 9
JO - Giordania 8
KE - Kenya 8
AO - Angola 7
CL - Cile 7
DZ - Algeria 7
HU - Ungheria 7
AL - Albania 6
BH - Bahrain 6
OM - Oman 6
PE - Perù 6
BO - Bolivia 5
CR - Costa Rica 5
ET - Etiopia 5
PA - Panama 5
PH - Filippine 5
RS - Serbia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
PS - Palestinian Territory 4
TH - Thailandia 4
BN - Brunei Darussalam 3
GR - Grecia 3
JM - Giamaica 3
KW - Kuwait 3
LV - Lettonia 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
GT - Guatemala 2
KG - Kirghizistan 2
SC - Seychelles 2
SN - Senegal 2
YE - Yemen 2
Totale 35.901
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.459
Singapore 2.148
Dallas 1.479
Hong Kong 1.290
Ashburn 1.260
Woodbridge 854
Dublin 817
Chandler 808
Frankfurt am Main 742
Houston 639
Milan 617
Ho Chi Minh City 601
Wilmington 551
Jacksonville 538
Fairfield 480
New York 468
Hanoi 455
Dearborn 436
Beijing 398
Santa Clara 388
Los Angeles 297
Princeton 282
Hefei 272
Seattle 224
Boardman 193
Nanjing 189
Shanghai 170
Seoul 147
Cambridge 142
Vienna 133
Jakarta 131
Buffalo 126
Chicago 112
Guangzhou 106
Moscow 106
Council Bluffs 100
São Paulo 100
The Dalles 94
Munich 91
Lachine 84
Lawrence 80
Dong Ket 77
Altamura 74
Helsinki 69
Tokyo 68
Shenyang 60
Nanchang 59
Toronto 59
Vilnius 57
Da Nang 52
Denver 51
Andover 49
Carate Brianza 49
Nuremberg 48
Ha Long 47
Haiphong 46
Pune 46
Grafing 45
London 45
Montreal 45
Phoenix 45
Rome 43
Chennai 42
Falls Church 42
Biên Hòa 41
Changsha 41
Hải Dương 41
Jinan 41
Warsaw 41
Brooklyn 40
Fremont 40
San Diego 40
Atlanta 39
Orem 39
Stockholm 38
Johannesburg 36
Tianjin 36
Jiaxing 35
Nürnberg 35
Poplar 35
Brussels 34
Zhengzhou 34
Rio de Janeiro 33
Bắc Ninh 32
Kunming 32
Ninh Bình 32
Can Tho 31
Columbus 31
Turku 31
Hangzhou 30
Quận Bình Thạnh 30
Kent 29
Mexico City 29
Amsterdam 28
Ottawa 28
Boston 27
San Francisco 27
Vũng Tàu 27
Melzo 26
Norwalk 26
Totale 23.040
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 518
CIPN and its mechanism of development 517
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 507
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 446
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 421
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 388
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
Age-related changes in the function and structure of the peripheral sensory pathway in mice 370
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Enhanced brain targeting of engineered solid lipid nanoparticles 341
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 333
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 319
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 308
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 305
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 303
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 291
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 291
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 285
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 284
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 275
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 272
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 268
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 265
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 265
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 260
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 259
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 258
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 256
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 254
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 254
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 253
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 251
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 251
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 250
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 249
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 247
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 246
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 241
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 239
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 239
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 239
Enhanced brain targeting of engineered solid lipid nanoparticles 238
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 236
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 235
OCT2 transporter involvement in development of cisplatin toxicity 235
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 232
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 230
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 230
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 230
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 229
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 228
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 228
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 226
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 225
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 225
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 220
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 219
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 219
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 218
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 218
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 218
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 217
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 216
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 216
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 215
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 215
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 214
Genetic factors influencing the development of vincristine-induced neurotoxicity 214
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 213
In vivo study of Carfilzomib-Induced Neuropathy 211
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 210
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 208
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 207
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 207
Multimodal experimental approach to the study of human neurological diseases 206
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 205
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 204
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 204
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 204
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 201
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 201
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 200
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 199
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 198
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 198
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 198
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 197
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 193
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 191
Totale 25.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.734 0 0 0 0 0 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20257.357 385 826 683 331 581 305 500 256 772 977 618 1.123
2025/202611.297 2.714 1.793 2.375 1.710 1.845 860 0 0 0 0 0 0
Totale 37.058